A history of breast enlargement
Explore the milestones behind EVEBRA, from early enlargement claims and implants to Dr. Khouri's work on external expansion. Each chapter separates company history from published evidence.
A visual archive with source notes for key clinical and regulatory milestones.
An evolving question
Early advertising promised enlargement without proof. Implants made a more selectable size possible through surgery. Later, surgeons and researchers explored fat grafting and external tissue expansion. EVEBRA grew from that last line of work: a wearable approach designed for sustained, gentle tension at home.
This timeline separates company history from published clinical findings. Research involving surgery or an earlier device should not be read as a trial of today's EVEBRA system.
Chapter 01 · 1897–1977
These archival images show how long the desire for a non-surgical route has existed. They record marketing history, not proof that the devices worked.
The Sears “Princess Bust Developer” is one of the early products in EVEBRA's archive. Its enlargement promise illustrates the era's appetite for an alternative to surgery, without establishing that it caused lasting growth.
The early 1960s mark a turning point for surgical breast augmentation. Implants offered a way to choose a more specific size, while adding the considerations of an operation and an implanted device.
Retail suction gadgets continued to be marketed for breast enlargement. Their brief use and promotional claims should not be confused with the later research on sustained external expansion.
Chapter 02 · 1987–2000
Breast surgery evolved while Dr. Roger Khouri began investigating whether an external device could apply the kind of sustained tension used in tissue expansion.
The American Society of Plastic Surgeons' predecessor advised against fat injection for augmentation, calling it experimental and raising concerns about breast imaging. This was an advisory position, not a claim that every future form of fat grafting was permanently prohibited.
Read the ASPS history
The FDA announced a voluntary moratorium on silicone gel implant sales in the United States while it reviewed safety information. New silicone gel implants were approved in 2006. The FDA continues to state that breast implants are not lifetime devices.
Read the FDA accountAfter years in complex breast reconstruction, Dr. Khouri began developing a wearable external expansion system. EVEBRA's archive traces his design work to the late 1990s; that development story is distinct from the clinical evidence published later.
Meet the inventor
The first pivotal publication
2000Khouri and colleagues published a small study of an earlier external soft-tissue expansion system. Seventeen women enrolled and 12 completed the protocol. MRI findings among completers supported enlargement of breast tissue rather than swelling alone. The study was single-group and did not test today's EVEBRA device.
Read the published paper
Chapter 03 · 2001–2016
The first consumer system also revealed the practical challenge: external expansion asks for consistent wear. A separate research track later paired pre-expansion with surgical fat transfer.
EVEBRA's predecessor put the external expansion concept into a wearable system. Its history matters because the method relied on hours of steady wear, rather than a short suction session. Published papers explored external expansion, but the earliest work should be read within its own study scope.
Understand the methodEVEBRA's archive records BRAVA coverage in fashion and news media, reflecting public interest in a non-surgical option. Media attention is distinct from clinical evidence.
The original system required patience and consistency. Its daily time commitment was a practical barrier, even for women drawn to the method.
BRAVA was no longer available by 2016, according to EVEBRA's archive. Dr. Khouri later developed EVE as a successor for use around fat-grafting care.
After reviewing the evidence, ASPS issued guiding principles in 2009. They did not provide a blanket clinical recommendation for fat grafting, but marked a change from the 1987 caution. This is a surgical topic separate from at-home expansion alone.
Read ASPS guiding principlesPublished studies examined BRAVA pre-expansion before fat transfer for augmentation or reconstruction. These procedures involved surgery; their outcomes cannot be used as a prediction for non-surgical EVEBRA wear.
Read the 2012 studyRead the 2014 study
Chapter 04 · 2017 onward
From EVE to EVEBRA, Dr. Khouri continued working on external expansion. Research in reconstruction and the current at-home product answer different questions.
According to EVEBRA's product history, Dr. Khouri developed EVE as a successor for use around fat-grafting care. Its role in a surgical pathway is separate from the later direct-to-consumer EVEBRA routine.
A Dutch randomized trial compared post-mastectomy reconstruction using external pre-expansion plus surgical fat transfer with implant-based reconstruction. It reported higher scores in three of five quality-of-life domains and fewer complications in the fat-transfer group. It did not test EVEBRA used alone for natural breast enlargement.
Read the JAMA Surgery trial
The current chapter
EVEBRAEVEBRA carries Dr. Khouri's external-expansion approach into a current at-home system. Its pressure-regulated pump, adjustable bra, Skin Seal and progressive dome sizes are designed for sustained low-level tension across a recommended 12-hour daily routine over 4–6 months. Individual results vary, and suitability and fit matter.
What changed in the design
The current EVEBRA product uses an adjustable bra, pressure-regulated pump, silicone rim skirts, Skin Seal and progressive dome sizes. These are design differences from the earlier BRAVA/EVE systems; they do not turn predecessor studies into trials of today's product.
See the current componentsRead beyond the timeline
Historical product images come from EVEBRA's existing archive. These external sources support the research and regulatory dates discussed above.
Research on BRAVA, EVE or a combined surgical procedure informs the history of the method. It does not establish an individual outcome with EVEBRA. Browse the EVEBRA publications page.
The original page's supporting imagery remains here for historical context. Some archive cards depict older products or surgical research, not the current EVEBRA device or its results.
Where the story goes next
Learn how the current device works, what its routine asks of you, and whether it may be suitable before you order.